Biotech Food Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization
Jun
29
2024
Cheers to this! Good News for the North Carolina Alcoholic Beverage Industry Ward and Smith, P.A.
Jun
28
2024
Biden-Harris Administration Announces Actions to Accelerate U.S. Domestic Biomanufacturing Capacity Bergeson & Campbell, P.C.
Jun
28
2024
Minnesota Department of Health Highlights Recent Publications on PFAS Bioaccumulation and PFAS in Infant Formula Bergeson & Campbell, P.C.
Jun
28
2024
Old North State Report – June 28, 2024 Nelson Mullins
Jun
28
2024
In Purdue Pharma, the Supreme Court Fires a Canon of Construction Through Non-Consensual Third-Party Releases (US) Squire Patton Boggs (US) LLP
Jun
28
2024
FDA Releases Update of Priority Guidance Topics for Foods Program Keller and Heckman LLP
Jun
28
2024
Codifying the Experimental Use Exception? USPTO Seeks Public Input Womble Bond Dickinson (US) LLP
Jun
28
2024
SCOTUS Update: Supreme Court Clarifies Organizational Standing in FDA-Related Ruling ArentFox Schiff LLP
Jun
27
2024
In Purdue Pharma, Supreme Court Rules That Nonconsensual Releases Are A Nonstarter Miller Canfield
Jun
27
2024
Aye, What’s the Deal with THCA? Unraveling Hemp’s Legal Knots Norris McLaughlin P.A.
Jun
27
2024
E for Effort? PI Analysis in Trade Secret Suit Riddled with Errors McDermott Will & Emery
Jun
26
2024
July 1 Deadline Looms for Cannabis Operators to Maintain and Renew Their Licenses by Entering into Labor Peace Agreements Sheppard, Mullin, Richter & Hampton LLP
Jun
26
2024
The 340B ‘Saga’ Continued: HRSA, States, and Drug Manufacturers Contest 340B Contract Pharmacy Restrictions in Court ArentFox Schiff LLP
Jun
26
2024
FDA Issues Warning Letter Related to Allergen Labeling Practices Keller and Heckman LLP
Jun
26
2024
CMS Issues FAQs to Aid Pharmacies in Preparing for Medicare Part B Coverage of PrEP Medications McDermott Will & Emery
Jun
26
2024
United States | AIC Special Report Notes 65% Growth in H-2 a Workers in US Agricultural Sector Berry Appleman & Leiden
Jun
25
2024
APHIS RFI Will Seek Comments on Options for Reducing Regulations for Modified Microbes Bergeson & Campbell, P.C.
Jun
25
2024
This Week in 340B: June 18 – 24, 2024 McDermott Will & Emery
Jun
25
2024
FDA Continues Response to Contaminated Applesauce Pouches Keller and Heckman LLP
Jun
25
2024
‘Big in a Small Town’: How Fast Food and QSRs are Transforming Small Town Dining ArentFox Schiff LLP
Jun
25
2024
Trending in Telehealth: June 4 – 10, 2024 McDermott Will & Emery
Jun
25
2024
China’s Supreme People’s Court Releases Two Recent Patent-Related Typical Anti-Monopoly Cases Schwegman, Lundberg & Woessner, P.A.
Jun
24
2024
China’s Supreme People’s Court: Drug Patent Reverse Payment Agreements May Violate the Anti-Monopoly Law Schwegman, Lundberg & Woessner, P.A.
Jun
24
2024
USPTO Publishes Drug Patent and Exclusivity Study Report Foley & Lardner LLP
Jun
24
2024
Healthcare Preview for the Week of: June 24, 2024 [Podcast] McDermott Will & Emery
Jun
21
2024
MoCRA Compliance: Key Legal Issues for Fashion Houses with Cosmetics ArentFox Schiff LLP
Jun
21
2024
CCC in Turmoil? Massachusetts Legislature Urged to Place Cannabis Control Commission in Receivership Blank Rome LLP
Jun
21
2024
Teva and DOJ May Reach Settlement in Closely Watched AKS Lawsuit ArentFox Schiff LLP
Jun
21
2024
California’s Occupational Safety and Health Standards Board Votes on Naloxone Requirement Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Jun
21
2024
USDA Proposes Revising Section 8e Import Inspection Fee Structure Keller and Heckman LLP
Jun
20
2024
FDA Updates Guidance on Intentional Genomic Alterations in Animals Womble Bond Dickinson (US) LLP
Jun
20
2024
CCC’s Model HCA & Approval Process Blank Rome LLP
Jun
20
2024
Rescheduling Timeline and Exclusions Blank Rome LLP
Jun
20
2024
The Future of Hemp-Derived THC Blank Rome LLP
Jun
20
2024
MDMA DOA at FDA Advisory Committee Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins